Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer.

Background Although combination therapy of S-1 and cisplatin (CDDP) has excellent efficacy against gastric cancer, the effect of the treatment on survival has been unclear. The aim of this study was to evaluate the long-term outcome of this combination therapy.